⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL926874 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL146984 | 0.97 | CYP3A4 (0.39) | — | |
| Oxalic Acid SCHEMBL11648148 | 0.88 | POLB (0.37) | — | |
| SCHEMBL122731 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL146194 | 0.81 | POLB (0.44) | — | |
| Trifluoroacetic Acid SCHEMBL20605362 | 0.81 | PTGES (0.36) | — | |
| SCHEMBL3043384 | 0.81 | POLB (0.44) | — | |
| SCHEMBL5853948 | 0.79 | PAOX (0.45) | — | |
| Hydrochloric Acid SCHEMBL1301180 | 0.79 | LMNA (0.44) | — | |
| SCHEMBL14865837 | 0.79 | PAOX (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 481 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270889-A1 | Fluorescently-Traceable Amino Acid Derivative And Preparation Methods And Use Thereof | Capital Medical University (CN) | 2023-08-31 | — | — | US | claimed |
| CN-111848544-B | Amino acid derivative capable of being traced by fluorescence and preparation method and application thereof | 首都医科大学 | 2022-03-04 | — | — | CN | claimed |
| CN-109251588-B | Inorganic nano material ink, preparation method and application thereof, and QLED device | TCL科技集团股份有限公司 | 2021-06-22 | — | — | CN | claimed |
| CN-111848544-A | Amino acid derivative capable of being traced by fluorescence and preparation method and application thereof | 首都医科大学 | 2020-10-30 | — | — | CN | claimed |
| CN-109251588-A | Inorganic nano material ink and its preparation method and application, QLED device | TCL集团股份有限公司 | 2019-01-22 | — | — | CN | claimed |
| EP-3034505-B1 | PROCESS FOR THE MANUFACTURE OF SPIROCYCLIC SUBSTITUTED BENZOFUROQUINOLIZINES | VETCARE OY (FI) | 2017-07-05 | — | — | EP | claimed |
| US-9695170-B2 | Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase | FIBROGEN, INC. (US) | 2017-07-04 | — | — | US | claimed |
| EP-2670750-B1 | NAPHTHYRIDINE DERIVATIVES AS INHIBITORS OF HYPOXIA INDUCIBLE FACTOR | FIBROGEN INC (US) | 2016-09-14 | — | — | EP | claimed |
| CN-105884634-A | Gossypol derivatives and preparation thereof, application of gossypol derivatives in pesticide and anti-cancer activity | 南开大学 | 2016-08-24 | — | — | CN | claimed |
| US-9409919-B2 | Process for the manufacture of spirocyclic substituted benzofuroquinolizines | VETCARE OY (FI) | 2016-08-09 | — | — | US | claimed |
| EP-0912559-B1 | FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LTD (GB) | 2002-11-06 | — | — | EP | claimed |
| US-6391874-B1 | ANTICARCINOGENIC AGENTS; SKIN DISORDERS | SMITHKLINE BEECHAM CORPORATION | 2002-05-21 | — | — | US | claimed |
| WO-2002036564-A1 | SULFONYLAMINO SUBSTITUTED 3-(AMINOMETHYLIDE)-2-INDOLINONES AS CELL PROLIFERATION INHIBITORS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2002-05-10 | — | — | WO | claimed |
| US-6207669-B1 | IN TREATMENT OF CANCER AND PSORIASIS | GLAXO WELLCOME INC. | 2001-03-27 | — | — | US | claimed |
| US-6174889-B1 | PROTEIN TYROSINE KINASE INHIBITORS RELATED TO BIOISOSTERES OF QUINOLINE AND QUINAZOLINE DERIVATIVES; ANTICARCINOGENIC AND -TUMOR AGENTS; PSORIASIS; RESTENOSIS; RHEUMATOID ARTHRITIS, AUTOIMMUNE DISEASE, ALLERGY, ASTHMA AND GRAFT REJECTION | GLAXO WELLCOME INC. | 2001-01-16 | — | — | US | claimed |
| EP-0912559-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1999-05-06 | — | — | EP | claimed |
| EP-0912572-A1 | BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1999-05-06 | — | — | EP | claimed |
| WO-1998002437-A1 | BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1998-01-22 | — | — | WO | claimed |
| WO-1998002434-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1998-01-22 | — | — | WO | claimed |
| EP-0438230-B1 | Indole-substituted five-membered heteroaromatic compounds | MERCK SHARP & DOHME (GB) | 1997-04-23 | — | — | EP | claimed |